LobbyingPharmaceutical Research and Manufacturers of America lobbying by quarter
Pharmaceutical Research and Manufacturers of America's latest lobbying report covers Q2 2026, at $500K. The four quarters Q4 2025–Q3 2026 total $1.4M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Pharmaceutical Research and Manufacturers of America
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.5M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $700K | 10 |
| Q1 2023 | $720K | 9 |
| Q2 2023 | $500K | 7 |
| Q3 2023 | $450K | 7 |
| Q4 2023 | $450K | 7 |
| Q1 2024 | $710K | 7 |
| Q2 2024 | $510K | 7 |
| Q3 2024 | $640K | 7 |
| Q4 2024 | $460K | 7 |
| Q1 2025 | $670K | 7 |
| Q2 2025 | $420K | 5 |
| Q3 2025 | $380K | 5 |
| Q4 2025 | $410K | 5 |
| Q1 2026 | $540K | 5 |
| Q2 2026 | $500K | 4 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$5.7M · 66 reports
- Medicare and Medicaid$966.7K · 34 reports
- Pharmacy$755K · 24 reports
- Trade$396.7K · 20 reports
- Defense$60K · 4 reports
- Economic development$0 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE74 reports
- HOUSE OF REPRESENTATIVES55 reports
- Health & Human Services, Dept of (HHS)30 reports
- Food & Drug Administration (FDA)15 reports
Firms it paid
| Firm | ||
|---|---|---|
| Arnold & Porter Kaye Scholer | $4.4M | 15 quarters |
| Capitol Counsel | $990K | 15 quarters |
| Tiber Creek Health Strategies | $660K | 14 quarters |
| Advanced Policy Consulting | $590K | 15 quarters |
| Desimone Consulting | $530K | 15 quarters |
| Ogr | $470K | 10 quarters |
| The Simmons & Russell Group | $450K | 10 quarters |
| Fti Government Affairs | $0 | 2 quarters |
| Klink Campaigns | $0 | 1 quarters |
| Tiger Hill Partners | $0 | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| PARI MODY | Intern, HHS Office of General Counsel Public Health (2013) | Q1 2026 |
| CHARLES PATRICK MICHAELS | Chief of Staff, Deputy Chief of Staff, Legislative Director, Senior Legislative Assistant, and Legislative Assistant, Rep. David Schweikert; Staff Assistant, Rep. Ted Budd; Intern, Senator James DeMint. | Q4 2025 |
| JOHN MARTIN | Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton. | Q4 2025 |
| KAREN STONE | Office of former Congressman Steve Israel (D-NY) [Legislative Correspondent/Staff Assistant, 2005; Senior Legislative Assistant, 2005-2009] Office of Congresswoman Dina Titus (D-NV) [Legislative Director, 2009-2010] | Q4 2025 |
| LISA WHISLER | Senior Policy Advisor, Sen. Max Baucus. | Q3 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | Capitol Counsel | $50K |
| 07/17for Q2 | Advanced Policy Consulting | $40K |
| 07/17for Q2 | Arnold & Porter Kaye Scholer | $380K |
| 07/14for Q2 | Desimone Consulting | $30K |
| 04/20for Q1 | Capitol Counsel | $50K |
| 04/20for Q1 | Arnold & Porter Kaye Scholer | $420K |
| 04/20for Q1 | Tiber Creek Health Strategies | Under $5,000 |
| 04/14for Q1 | Desimone Consulting | $30K |
| 04/14for Q1 | Advanced Policy Consulting | $40K |
| 01/20for Q4 2025 | Capitol Counsel | $40K |
| 01/20for Q4 2025 | Tiber Creek Health Strategies | $50K |
| 01/17for Q4 2025 | Advanced Policy Consulting | $40K |
| 01/17for Q4 2025 | Desimone Consulting | $40K |
| 01/16for Q4 2025 | Arnold & Porter Kaye Scholer | $240K |
| 25/10/19for Q3 2025 | Tiber Creek Health Strategies | $50K |
| 25/10/19for Q3 2025 | Capitol Counsel | $50K |
| 25/10/16for Q3 2025 | Arnold & Porter Kaye Scholer | $210K |
| 25/10/15for Q3 2025 | Desimone Consulting | $30K |
| 25/10/08for Q3 2025 | Advanced Policy Consulting | $40K |
| 25/07/21for Q2 2025 | Capitol Counsel | $40K |